Download interactions: TXT MITAB-2.5
Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
---|---|---|---|---|---|---|
GDN
Glia-derived nexin |
4 |
20 |
Small-scale |
0.899 | High |
|
PAI1
Plasminogen activator inhibitor 1 |
4 |
20 |
Small-scale |
0.896 | High |
|
UPAR
Urokinase plasminogen activator surface receptor |
6 |
0 |
Small-scale |
0.895 | High |
|
PAI2
Plasminogen activator inhibitor 2 |
2 |
20 |
Small-scale |
0.799 | High |
|
SLUR1
Secreted Ly-6/uPAR-related protein 1 |
2 |
2 |
Small-scale |
0.799 | High |
|
IPSP
Plasma serine protease inhibitor |
2 |
20 |
Small-scale |
0.778 | High |
|
BTK
Tyrosine-protein kinase BTK |
1 |
2 |
High-throughput |
0.698 | High |
|
ISLR
Immunoglobulin superfamily containing leucine-rich repeat protein |
1 |
7 |
High-throughput |
0.691 | High |
|
KLK1
Kallikrein-1 |
1 |
16 |
High-throughput |
0.691 | High |
|
FSTL4
Follistatin-related protein 4 |
1 |
4 |
High-throughput |
0.691 | High |
|
A4
Amyloid-beta precursor protein |
1 |
14 |
High-throughput |
0.665 | High |
|
TPA
Tissue-type plasminogen activator |
1 |
16 |
Small-scale |
0.647 | High |
|
LRP2
Low-density lipoprotein receptor-related protein 2 |
1 |
7 |
Small-scale |
0.647 | High |
|
PDGFC
Platelet-derived growth factor C |
1 |
14 |
Small-scale |
0.647 | High |
|
OIT3
Oncoprotein-induced transcript 3 protein |
1 |
9 |
High-throughput |
0.618 | High |
|
TX101
Testis-expressed protein 101 |
1 |
1 |
Small-scale |
0.618 | High |
|
ADA28
Disintegrin and metalloproteinase domain-containing protein 28 |
2 |
8 |
High-throughput |
0.606 | High |
|
MYC
Myc proto-oncogene protein |
2 |
10 |
High-throughput |
0.561 | High |
|
KPCD1
Serine/threonine-protein kinase D1 |
2 |
0 |
High-throughput |
0.547 | High |
|
POTEF
POTE ankyrin domain family member F |
1 |
3 |
High-throughput |
0.536 | High |
|
LY86
Lymphocyte antigen 86 |
1 |
2 |
High-throughput |
0.536 | High |
|
CFC1
Cryptic protein |
1 |
1 |
High-throughput |
0.536 | High |
|
PSPC
Surfactant protein C |
1 |
3 |
High-throughput |
0.536 | High |
|
PRG2
Bone marrow proteoglycan |
1 |
2 |
High-throughput |
0.536 | High |
|
PGFRA
Platelet-derived growth factor receptor alpha |
1 |
5 |
High-throughput |
0.536 | High |
|
CAH6
Carbonic anhydrase 6 |
1 |
2 |
High-throughput |
0.536 | High |
|
MFAP4
Microfibril-associated glycoprotein 4 |
1 |
7 |
High-throughput |
0.536 | High |
|
KLRD1
Natural killer cells antigen CD94 |
1 |
2 |
High-throughput |
0.536 | High |
|
PTC1
Protein patched homolog 1 |
1 |
2 |
High-throughput |
0.536 | High |
|
CST11
Cystatin-11 |
1 |
2 |
High-throughput |
0.536 | High |
|
GILT
Gamma-interferon-inducible lysosomal thiol reductase |
1 |
0 |
High-throughput |
0.513 | High |
|
DNSL1
Deoxyribonuclease-1-like 1 |
1 |
0 |
High-throughput |
0.513 | High |
|
FIBIN
Fin bud initiation factor homolog |
1 |
0 |
High-throughput |
0.513 | High |
|
HEM1
5-aminolevulinate synthase, non-specific, mitochondrial |
1 |
2 |
High-throughput |
0.494 | High |
|
SDF2L
Stromal cell-derived factor 2-like protein 1 |
1 |
3 |
High-throughput |
0.489 | High |
|
SCAM5
Secretory carrier-associated membrane protein 5 |
1 |
1 |
High-throughput |
0.481 | High |
|
GPC1
Glypican-1 [Cleaved into: Secreted glypican-1] |
1 |
7 |
High-throughput |
0.479 | High |
|
NUP35
Nucleoporin NUP35 |
1 |
0 |
High-throughput |
0.458 | High |
|
CEBPG
CCAAT/enhancer-binding protein gamma |
1 |
1 |
High-throughput |
0.457 | High |
|
PK3CA
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform |
1 |
2 |
High-throughput |
0.445 | High |
|
PBX1
Pre-B-cell leukemia transcription factor 1 |
1 |
2 |
Small-scale |
0.437 | High |
|
PKNX1
Homeobox protein PKNOX1 |
1 |
2 |
Small-scale |
0.437 | High |
|
MOCOS
Molybdenum cofactor sulfurase |
3 |
0 |
High-throughput |
0.347 | High |
|
KAT8
Histone acetyltransferase KAT8 |
1 |
0 |
Small-scale |
0.261 | Low |
|
PP4R4
Serine/threonine-protein phosphatase 4 regulatory subunit 4 |
1 |
0 |
High-throughput |
0.249 | Low |
|
RYBP
RING1 and YY1-binding protein |
1 |
0 |
High-throughput |
0.232 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024